Nanocarriers Usage for Drug Delivery in Cancer Therapy | Zendy

Hadi Khodabandehloo | Zendy; Hamid Zahednasab | Zendy; Asghar Ashrafi Hafez | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Nanocarriers Usage for Drug Delivery in Cancer Therapy

Author(s) -

Hadi Khodabandehloo,

Hamid Zahednasab,

Asghar Ashrafi Hafez

Publication year - 2016

Publication title -

iranian journal of cancer prevention

Language(s) - English

Resource type - Journals

eISSN - 2008-2401

pISSN - 2008-2398

DOI - 10.17795/ijcp-3966

Subject(s) - nanocarriers , medicine , drug carrier , liposome , drug delivery , site of action , drug , dendrimer , cancer therapy , pharmacology , targeted drug delivery , therapeutic index , nanomedicine , nanotechnology , cancer , materials science , nanoparticle , polymer chemistry

Conventional therapeutic agents have displayed significant shortcomings. For this reason, important achievements have effectively made in biotechnology for delivering the therapeutic agents to the site of action, and diminish side effects. Polymeric carriers, micelles, dendrimers, liposomes, solid lipid carriers, gold carriers, viral carriers, nanotubes and magnetic carriers incorporating cytotoxic therapeutics have developed. To improve biological distribution of therapeutic drugs, some modified carriers have designed in optimal size and modified surface area. Delivery of carriers to target cells could be done by passive and active targeting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research